Natco Pharma - Next Leg
A fundamentally sound company with a super management.
The stock could be due its next leg. It had a recent breakout retest and successfuly bounced.
Long above 900% SL 3-5% below purchase price. Its not a trading buy but more for an investment kind of play.
The stock could be due its next leg. It had a recent breakout retest and successfuly bounced.
Long above 900% SL 3-5% below purchase price. Its not a trading buy but more for an investment kind of play.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。